LANTHEUS HOLDINGS INC. - COMMON STOCK

Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time

18 Apr 2024 08:00:00 By Nasdaq GlobeNewswire

Lantheus to Present at the Leerink Partners Global Biopharma Conference 2024

05 Mar 2024 08:30:00 By Nasdaq GlobeNewswire

Lantheus Announces the FDA Approval of DEFINITY® (Perflutren Lipid Microsphere) for Pediatric Patients

04 Mar 2024 08:30:00 By Nasdaq GlobeNewswire

Lantheus Announces Promotion of Amanda Morgan to Chief Commercial Officer

28 Feb 2024 08:30:00 By Nasdaq GlobeNewswire

Lantheus to Present at the TD Cowen 44th Annual Health Care Conference

26 Feb 2024 08:30:00 By Nasdaq GlobeNewswire

Lantheus Reports Fourth Quarter and Full Year 2023 Financial Results

22 Feb 2024 07:00:00 By Nasdaq GlobeNewswire

Lantheus Announces Collaboration to Provide Novel Tau Imaging Agent for Large Consortium Clinical Trial Sponsored by the National Institute on Aging

13 Feb 2024 08:30:00 By Nasdaq GlobeNewswire

Lantheus to Host Fourth Quarter and Full Year 2023 Earnings Conference Call and Webcast on February 22, 2024, at 8:00 a.m. Eastern Time

08 Feb 2024 08:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: LANTHEUS HOLDINGS INC. - COMMON STOCK

23 Jan 2024 09:45:39 By NetDania Notify

Lantheus Announces CEO Succession Plan

23 Jan 2024 07:45:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: LANTHEUS HOLDINGS INC. - COMMON STOCK

19 Jan 2024 12:25:48 By NetDania Notify

Lantheus Announces Acceptance of its First-to-File ANDA for Generic LUTATHERA® (Lutetium Lu 177 Dotatate)

11 Jan 2024 08:00:00 By Nasdaq GlobeNewswire

Lantheus Expands Radiopharmaceutical Oncology Pipeline via Strategic Agreements with Perspective Therapeutics

09 Jan 2024 08:00:00 By Nasdaq GlobeNewswire

Lantheus Reports Preliminary Fiscal Year 2023 Revenue

09 Jan 2024 07:55:00 By Nasdaq GlobeNewswire

Lantheus to Present at the 42nd Annual J.P. Morgan Healthcare Conference

03 Jan 2024 08:30:00 By Nasdaq GlobeNewswire

Lantheus and POINT Biopharma Announce Positive Topline Results from Pivotal SPLASH Trial in Metastatic Castration-Resistant Prostate Cancer

18 Dec 2023 07:30:00 By Nasdaq GlobeNewswire

Lantheus to Present at the Jefferies London Healthcare Conference

08 Nov 2023 08:00:00 By Nasdaq GlobeNewswire

Lantheus Reports Third Quarter 2023 Financial Results

02 Nov 2023 07:00:01 By Nasdaq GlobeNewswire

Lantheus to Host Third Quarter 2023 Earnings Conference Call and Webcast on November 2, 2023, at 8:00 a.m. Eastern Time

19 Oct 2023 08:00:00 By Nasdaq GlobeNewswire

Lantheus Announces Top Rated Oral Presentation Featuring PYLARIFY AI™ at the 2023 European Association of Nuclear Medicine (EANM) Annual Meeting

01 Sep 2023 08:30:00 By Nasdaq GlobeNewswire